Study of a new drug for high triglycerides
Part of Hormones & metabolism clinical trials.
This study tests a new drug, HRS-7249, to see if it safely lowers high triglyceride levels (a type of fat in the blood) that can increase the risk of heart problems. It is for people who either were in the earlier study of this drug or are new participants with high triglycerides.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 79 years old.
- You must have high levels of fats (triglycerides) in your blood, confirmed by a blood test.
- You must be willing to follow a healthy lifestyle and limit alcohol to no more than one small drink per day.
- You cannot have had a heart attack, stroke, or major blood vessel surgery in the past 3 months.
- You cannot have certain serious illnesses, such as unstable heart failure or severe liver disease.
- If you can become pregnant, you must use reliable birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This early-stage trial tests an investigational drug called ISH0688 to see if it is safe and how well it works in people with high triglycerides (a type of fat in the blood). The study is also checking how the body absorbs and processes the drug.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This study tests a new medicine called DR10624 to see if it can lower very high levels of triglycerides (a type of fat in the blood) in people who have not been helped enough by standard treatments. The study compares the new drug to a placebo (a dummy shot) over several months.
This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.
This trial compares how well different forms of an experimental drug are absorbed by the body. Healthy volunteers will receive the drug and have blood tests to see which version works best.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.